A medication adjustment or additional treatment may be needed
[21] [22] Conversely, symptoms of adrenal insufficiency such as severe fatigue, weight loss, hypotension, or hypoglycemia require urgent assessment, typically starting with morning serum cortisol and possibly ACTH stimulation testing
If more than 5 days late, skip to the next scheduled dose
approvals: T2D (Mounjaro, 2022), obesity (Zepbound, 2023), and obstructive sleep apnea with obesity (Zepbound, 2024) Ongoing Innovations in GLP-1s Landscape The obesity pipeline from phase 1 to market now includes 173 drugs, with GLP-1 and combination therapies accounting for majority of trials
Meaning they are both extremely important for our bodies, almost like joint gold medal winners
Semaglutide is not a controlled substance and is not currently part of any military testing expansion